Supplements
Pharmacists’ Guide to Menopause Management
July 2025 Influenza Guide for Pharmacists
Advancing Screening for Chronic Kidney Disease: The Expanding Role of Pharmacists
This program is made possible by an independent grant from Boehringer Ingleheim Pharmaceuticals, Inc. and Eli Lilly and Company.
Optimizing Delivery of Nimodipine in Patients With Subarachnoid Hemorrhage
This article is sponsored by Azurity Pharmaceuticals, Inc
July 2024 RSV Guide for Pharmacists
July 2024 Influenza Guide for Pharmacists
October 2023 Pharmacy Technician Edition
Volume: 7
September 2023 Immunization Guide for Pharmacists
July 2023 Influenza Supplement
June 2023 Immunization Guide for Pharmacists
April 2023 Technician Supplement
Volume: 6
October 2022 Technician Supplement
Volume: 5
October 2022 Immunization Supplement
July 2022 Influenza Supplement
June 2022 Immunization Guide for Pharmacists
April 2022 Technician Supplement
Volume: 4
Brukinsa® zanubrutinib 80mg capsules: Clinical Monograph
November 2021 Technician Supplement
Volume: 3
October 2021 Immunization Guide for Pharmacists
August 2021 Immunization Supplement
Influenza Guide for Pharmacists July 2021
Technician Supplement April 2021
Volume: 2
Issue: 1
Technician Supplement April 2021
Immunization Guide for Pharmacists November 2020
Volume: 2
Issue: 2
Pharmacy Technician Edition October 2020
Volume: 1
Issue: 1
Immunization Guide for Pharmacists August 2020
Volume: 2
Issue: 1
Influenza Guide for Pharmacists
Volume: 1
Issue: 1
COVID-19 Guide for Pharmacists
Volume: 1
Issue: 1
Vitamin and Supplements Guide for Pharmacists
Volume: 1
Issue: 1
Immunization Guide for Pharmacists November 2019
Volume: 1
Issue: 5
Immunization Guide for Pharmacists
Volume: 1
Issue: 4
Advertisement
Advertisement
Trending on Pharmacy Times
1
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
2
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
3
FDA Approves Targeted Combination Therapy for BRCA2-Mutated Prostate Cancer
4
Targeted ADCs Break Through Barriers in HER2-Positive Breast Cancer
5
